Alnylam Pharmaceuticals Shares Down 25.0% Since SmarTrend's Sell Call (ALNY)
January 26, 2016 at 15:58 PM EST
SmarTrend identified a Downtrend for Alnylam Pharmaceuticals (NASDAQ:ALNY) on December 8th, 2015 at $98.27. In approximately 2 months, Alnylam Pharmaceuticals has returned 24.98% as of today's recent price of...